These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19079233)

  • 1. Epithelial apoptosis is a prominent feature of the epithelial barrier disturbance in intestinal inflammation: effect of pro-inflammatory interleukin-13 on epithelial cell function.
    Heller F; Fromm A; Gitter AH; Mankertz J; Schulzke JD
    Mucosal Immunol; 2008 Nov; 1 Suppl 1():S58-61. PubMed ID: 19079233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution.
    Heller F; Florian P; Bojarski C; Richter J; Christ M; Hillenbrand B; Mankertz J; Gitter AH; Bürgel N; Fromm M; Zeitz M; Fuss I; Strober W; Schulzke JD
    Gastroenterology; 2005 Aug; 129(2):550-64. PubMed ID: 16083712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial tight junctions in intestinal inflammation.
    Schulzke JD; Ploeger S; Amasheh M; Fromm A; Zeissig S; Troeger H; Richter J; Bojarski C; Schumann M; Fromm M
    Ann N Y Acad Sci; 2009 May; 1165():294-300. PubMed ID: 19538319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease.
    Zeissig S; Bürgel N; Günzel D; Richter J; Mankertz J; Wahnschaffe U; Kroesen AJ; Zeitz M; Fromm M; Schulzke JD
    Gut; 2007 Jan; 56(1):61-72. PubMed ID: 16822808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications.
    Mankertz J; Schulzke JD
    Curr Opin Gastroenterol; 2007 Jul; 23(4):379-83. PubMed ID: 17545772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase 7 contributes to intestinal barrier dysfunction by degrading tight junction protein Claudin-7.
    Xiao Y; Lian H; Zhong XS; Krishnachaitanya SS; Cong Y; Dashwood RH; Savidge TC; Powell DW; Liu X; Li Q
    Front Immunol; 2022; 13():1020902. PubMed ID: 36275703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The JAK-Inhibitor Tofacitinib Rescues Human Intestinal Epithelial Cells and Colonoids from Cytokine-Induced Barrier Dysfunction.
    Sayoc-Becerra A; Krishnan M; Fan S; Jimenez J; Hernandez R; Gibson K; Preciado R; Butt G; McCole DF
    Inflamm Bowel Dis; 2020 Feb; 26(3):407-422. PubMed ID: 31751457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guanylate-binding protein-1 is expressed at tight junctions of intestinal epithelial cells in response to interferon-gamma and regulates barrier function through effects on apoptosis.
    Schnoor M; Betanzos A; Weber DA; Parkos CA
    Mucosal Immunol; 2009 Jan; 2(1):33-42. PubMed ID: 19079332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoids regulate barrier function and claudin expression in intestinal epithelial cells via MKP-1.
    Fischer A; Gluth M; Weege F; Pape UF; Wiedenmann B; Baumgart DC; Theuring F
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G218-28. PubMed ID: 24309183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guanylate binding protein-1-mediated epithelial barrier in human salivary gland duct epithelium.
    Konno T; Takano K; Kaneko Y; Kakuki T; Nomura K; Yajima R; Kakiuchi A; Kohno T; Himi T; Kojima T
    Exp Cell Res; 2018 Oct; 371(1):31-41. PubMed ID: 30044945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients.
    Epple HJ; Schneider T; Troeger H; Kunkel D; Allers K; Moos V; Amasheh M; Loddenkemper C; Fromm M; Zeitz M; Schulzke JD
    Gut; 2009 Feb; 58(2):220-7. PubMed ID: 18936106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune-Mediated Aggravation of the
    Nattramilarasu PK; Lobo de Sá FD; Schulzke JD; Bücker R
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669494
    [No Abstract]   [Full Text] [Related]  

  • 14. STAT6 activation in ulcerative colitis: a new target for prevention of IL-13-induced colon epithelial cell dysfunction.
    Rosen MJ; Frey MR; Washington MK; Chaturvedi R; Kuhnhein LA; Matta P; Revetta FL; Wilson KT; Polk DB
    Inflamm Bowel Dis; 2011 Nov; 17(11):2224-34. PubMed ID: 21308881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms.
    Bruewer M; Luegering A; Kucharzik T; Parkos CA; Madara JL; Hopkins AM; Nusrat A
    J Immunol; 2003 Dec; 171(11):6164-72. PubMed ID: 14634132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis.
    Su L; Nalle SC; Shen L; Turner ES; Singh G; Breskin LA; Khramtsova EA; Khramtsova G; Tsai PY; Fu YX; Abraham C; Turner JR
    Gastroenterology; 2013 Aug; 145(2):407-15. PubMed ID: 23619146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-mouse CD52 monoclonal antibody ameliorates intestinal epithelial barrier function in interleukin-10 knockout mice with spontaneous chronic colitis.
    Wang H; Dong J; Shi P; Liu J; Zuo L; Li Y; Gong J; Gu L; Zhao J; Zhang L; Zhang W; Zhu W; Li N; Li J
    Immunology; 2015 Feb; 144(2):254-62. PubMed ID: 25087772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tight junctions and cell-cell interactions.
    Utech M; Brüwer M; Nusrat A
    Methods Mol Biol; 2006; 341():185-95. PubMed ID: 16799199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing regulation of the tight junction protein claudin-2 by interferon-gamma and interleukin-4.
    Wisner DM; Harris LR; Green CL; Poritz LS
    J Surg Res; 2008 Jan; 144(1):1-7. PubMed ID: 17640674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral and fecal Campylobacter concisus strains perturb barrier function by apoptosis induction in HT-29/B6 intestinal epithelial cells.
    Nielsen HL; Nielsen H; Ejlertsen T; Engberg J; Günzel D; Zeitz M; Hering NA; Fromm M; Schulzke JD; Bücker R
    PLoS One; 2011; 6(8):e23858. PubMed ID: 21887334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.